Safety Alerts & Recalls
What does this mean?
This recall for Nifediac CC Extended Release 60 mg tablets was issued at a warehouse and pharmacy level only. The FDA and the manufacturer have determined that any recalled product that may have been dispensed to patients does not pose a significant health risk. However, if you take Nifedipine CC Extended Release 60 mg tablets, follow up with your doctor or pharmacy if you are concerned or are experiencing side effects.
Select Lots of Nifediac CC Extended Release 60 mg Tablets Recalled By Biovail Pharmaceuticals
Biovail Pharmaceuticals has recalled two lots of Nifediac CC (Nifedipine) Extended Release Tablets, 60 mg. Lot numbers 0804T28 and 0807T25 are being recalled because they failed the manufacturer routine tests that measure the rate the tablet releases the active medicine. Tablets in these lots may release the active ingredient at a slightly faster rate than required.
Nifediac CC contains the active ingredient nifedipine and is commonly used in the treatment of high blood pressure and angina (chest pain). Nifedipine is also sold under generic name and other brand names, including Adalat CC, Afeditab CR, Procardia, and Procardia XL. This recall alert only applies to these two lots of Nifediac CC (Nifedipine) Extended Release Tables, 60 mg. No other nifedipine products are involved in this recall.
To view the FDA notice about this recall, please visit: more information here